[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - FRI0214 Long-term efficacy and safety of sirukumab in patients with active rheumatoid arthritis despite anti-tumor necrosis factor therapy: results of the randomized, phase 3 sirround-t study
Tanaka, Y, Aletaha, D, Agarwal, P, Kurrasch, R, Tak, PP, Popik, SLanguage:
english
DOI:
10.1136/annrheumdis-2017-eular.6486
File:
PDF, 172 KB
english